|
|
|
Insider
Information: |
Boyd Steven |
Relationship: |
10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
18 |
|
Direct
Shares |
47,075,098 |
|
Indirect Shares
|
40,287,245 |
|
|
Direct
Value |
$124,110,593 |
|
|
Indirect Value
|
$39,455,039 |
|
|
Total
Shares |
87,362,343 |
|
|
Total
Value |
$163,565,632 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
99
|
96
|
Stock
price went up :
|
54
|
46
|
Stock
price went down : |
45
|
50
|
|
|
|
Gain/Loss Ratio : |
1.2
|
1.2
|
Percentage
Gain/Loss : |
-16.7%
|
8,928.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2023-06-27 |
34,370 |
2023-06-27 |
731,458 |
Premium* |
|
Dynatronics Corp |
DYNT |
10% Owner |
2017-03-21 |
500,000 |
2017-03-21 |
1,000,000 |
Premium* |
|
Kiora Pharmaceuticals |
KPRX |
10% Owner |
2021-01-06 |
3,346,601 |
2021-08-02 |
785,000 |
Premium* |
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
10% Owner |
2019-01-10 |
2,170,000 |
2019-01-10 |
2,170,000 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2018-02-06 |
6,936,000 |
2018-02-06 |
6,936,000 |
Premium* |
|
Cassava Sciences Inc |
SAVA |
10% Owner |
2018-10-03 |
1,651,340 |
2018-10-03 |
0 |
Premium* |
|
Del Friscos Restaurant Group, Llc |
DFRG |
10% Owner |
2019-09-25 |
0 |
2019-09-25 |
0 |
Premium* |
|
Valeritas Holdings Inc |
VLRX |
10% Owner |
2019-12-20 |
0 |
2019-12-20 |
0 |
Premium* |
|
Bio-Path Holdings, Inc. |
BPTH |
10% Owner |
2019-01-18 |
129,298 |
2019-01-18 |
129,298 |
Premium* |
|
AYTU BIOSCIENCE, INC |
AYTU |
Director |
2021-03-29 |
1,342,378 |
2021-03-29 |
1,342,378 |
Premium* |
|
Achieve Life Sciences Inc |
ACHV |
10% Owner |
2019-06-11 |
843,776 |
2019-06-11 |
843,776 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
10% Owner |
2020-03-16 |
4,120,000 |
2020-03-16 |
348,000 |
Premium* |
|
Onconova Therapeutics, Inc. |
ONTX |
10% Owner |
2019-09-23 |
816,702 |
2019-09-23 |
816,702 |
Premium* |
|
Vaxart Inc |
VXRT |
Director |
2020-06-29 |
145,523 |
2020-06-29 |
145,523 |
Premium* |
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director, 10% Owner |
2020-07-28 |
0 |
2020-07-28 |
0 |
Premium* |
|
Tenax Therapeutics Inc |
TENX |
Director, 10% Owner |
2020-09-08 |
2,019,995 |
2020-09-08 |
2,019,995 |
Premium* |
|
Cyclo Therapeutics, Inc |
CYTH |
10% Owner |
2020-09-30 |
15,795,769 |
2020-09-30 |
15,795,769 |
Premium* |
|
ReShape Lifesciences Inc |
RSLS |
10% Owner |
2021-06-28 |
7,223,346 |
2021-06-28 |
7,223,346 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
790 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 28 of 32
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-09-01 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
1,931,995 |
2.17 |
% |
|
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-09-02 |
4 |
B |
$1.47 |
$29,400 |
D/D |
20,000 |
1,951,995 |
3.92 |
% |
|
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-09-02 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
1,951,995 |
2.17 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-03 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
18,808,308 |
0 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-03 |
4 |
S |
$0.16 |
$8,557 |
D/D |
(53,479) |
18,808,308 |
0 |
% |
|
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-09-03 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
1,987,995 |
2.17 |
% |
|
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-09-03 |
4 |
B |
$1.39 |
$50,040 |
D/D |
36,000 |
1,987,995 |
3.92 |
% |
|
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-09-04 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
2,011,452 |
2.17 |
% |
|
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-09-04 |
4 |
B |
$1.41 |
$33,074 |
D/D |
23,457 |
2,011,452 |
3.92 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-09-04 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
30,014,285 |
2.17 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-09-04 |
4 |
B |
$2.20 |
$220,000 |
D/D |
100,000 |
30,014,285 |
3.92 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-04 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
18,694,308 |
0 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-04 |
4 |
S |
$0.16 |
$18,240 |
D/D |
(114,000) |
18,694,308 |
0 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-08 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
17,356,826 |
0 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-08 |
4 |
S |
$0.16 |
$213,997 |
D/D |
(1,337,482) |
17,356,826 |
0 |
% |
|
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-09-08 |
4 |
B |
$1.46 |
$12,473 |
D/D |
8,543 |
2,019,995 |
3.92 |
% |
|
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-09-08 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
2,019,995 |
2.17 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-09 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
16,806,076 |
0 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-09 |
4 |
S |
$0.18 |
$99,103 |
D/D |
(550,570) |
16,806,076 |
0 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-10 |
4 |
S |
$0.17 |
$48,025 |
D/D |
(282,500) |
16,523,576 |
0 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-10 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
16,523,576 |
0 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-11 |
4 |
S |
$0.17 |
$28,900 |
D/D |
(170,000) |
16,353,576 |
0 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-11 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
16,353,576 |
0 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-14 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
16,223,576 |
0 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-14 |
4 |
S |
$0.17 |
$22,100 |
D/D |
(130,000) |
16,223,576 |
0 |
% |
|
790 Records found
|
|
Page 28 of 32 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|